Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 348

1.

Screening Test for HTLV-III (AIDS Agent) Antibodies: Specificity, Sensitivity, and Applications.

Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA; AIDS Seroepidemiology Collaborative Working Group.

JAMA. 2014 Jul 23;312(4):442. doi: 10.1001/jama.2013.279636. No abstract available.

PMID:
25038372
[PubMed - in process]
2.

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA.

J Neurovirol. 2014 Aug;20(4):380-7. doi: 10.1007/s13365-014-0254-6. Epub 2014 Jun 14.

PMID:
24927825
[PubMed - in process]
3.

Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort.

Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM.

J Clin Virol. 2013 Dec;58 Suppl 1:e113-8. doi: 10.1016/j.jcv.2013.08.017.

PMID:
24342470
[PubMed - in process]
4.

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Ezati N, Mosunmola I, Hungerford L, Brown C, Tracy KJ, Obasanya J, Blattner W.

Tuberc Res Treat. 2013;2013:650561. doi: 10.1155/2013/650561. Epub 2013 Jul 16.

PMID:
23970967
[PubMed]
Free PMC Article
5.

Elevated hypermutation levels in HIV-1 natural viral suppressors.

Eyzaguirre LM, Charurat M, Redfield RR, Blattner WA, Carr JK, Sajadi MM.

Virology. 2013 Sep 1;443(2):306-12. doi: 10.1016/j.virol.2013.05.019. Epub 2013 Jun 19.

PMID:
23791226
[PubMed - indexed for MEDLINE]
6.

Cervical cancer risk factors among HIV-infected Nigerian women.

Ononogbu U, Almujtaba M, Modibbo F, Lawal I, Offiong R, Olaniyan O, Dakum P, Spiegelman D, Blattner W, Adebamowo C.

BMC Public Health. 2013 Jun 14;13:582. doi: 10.1186/1471-2458-13-582.

PMID:
23767681
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W.

PLoS One. 2013 May 9;8(5):e63170. doi: 10.1371/journal.pone.0063170. Print 2013.

PMID:
23671669
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria.

Anude CJ, Eze E, Onyegbutulem HC, Charurat M, Etiebet MA, Ajayi S, Dakum P, Akinwande O, Beyrer C, Abimiku A, Blattner W.

BMC Infect Dis. 2013 Mar 1;13:113. doi: 10.1186/1471-2334-13-113.

PMID:
23452915
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Immunologic outcomes of antiretroviral therapy among HIV-infected Nigerian children and its association with early infant feeding and nutritional status at treatment initiation.

Omoni AO, Christian PS, Sadoh WE, Okechukwu A, Olateju E, Omoigberale A, Blattner W, Charurat ME.

Pediatr Infect Dis J. 2013 Jul;32(7):e291-7. doi: 10.1097/INF.0b013e31828b2a2f.

PMID:
23411626
[PubMed - indexed for MEDLINE]
10.

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

Yates NL, Stacey AR, Nolen TL, Vandergrift NA, Moody MA, Montefiori DC, Weinhold KJ, Blattner WA, Borrow P, Shattock R, Cohen MS, Haynes BF, Tomaras GD.

Mucosal Immunol. 2013 Jul;6(4):692-703. doi: 10.1038/mi.2012.107. Epub 2013 Jan 9.

PMID:
23299618
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy.

Etiebet MA, Shepherd J, Nowak RG, Charurat M, Chang H, Ajayi S, Elegba O, Ndembi N, Abimiku A, Carr JK, Eyzaguirre LM, Blattner WA.

AIDS. 2013 Feb 20;27(4):553-61. doi: 10.1097/QAD.0b013e32835b0f59.

PMID:
23079810
[PubMed - indexed for MEDLINE]
12.

HIV counseling and testing and access-to-care needs of populations most-at-risk for HIV in Nigeria.

Ahmed S, Delaney K, Villalba-Diebold P, Aliyu G, Constantine N, Ememabelem M, Vertefeuille J, Blattner W, Nasidi A, Charurat M.

AIDS Care. 2013;25(1):85-94. doi: 10.1080/09540121.2012.686597. Epub 2012 Jun 18.

PMID:
22709242
[PubMed - indexed for MEDLINE]
13.

The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study.

Jedy-Agba EE, Curado MP, Oga E, Samaila MO, Ezeome ER, Obiorah C, Erinomo OO, Ekanem IO, Uka C, Mayun A, Afolayan EA, Abiodun P, Olasode BJ, Omonisi A, Otu T, Osinubi P, Dakum P, Blattner W, Adebamowo CA.

Cancer Epidemiol. 2012 Oct;36(5):430-5. doi: 10.1016/j.canep.2012.05.010. Epub 2012 Jun 15.

PMID:
22704971
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cancer incidence in Nigeria: a report from population-based cancer registries.

Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, Osubor G, Otu T, Kumai H, Koechlin A, Osinubi P, Dakum P, Blattner W, Adebamowo CA.

Cancer Epidemiol. 2012 Oct;36(5):e271-8. doi: 10.1016/j.canep.2012.04.007. Epub 2012 May 22.

PMID:
22621842
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.

Royal W 3rd, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA.

J Neurovirol. 2012 Jun;18(3):191-9. doi: 10.1007/s13365-012-0097-y. Epub 2012 Apr 18. Erratum in: J Neurovirol. 2012 Oct;18(5):441. McCutchen, J Allen [corrected to McCutchan, J Allen].

PMID:
22528480
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Characterization of acute HIV-1 infection in high-risk Nigerian populations.

Charurat M, Nasidi A, Delaney K, Saidu A, Croxton T, Mondal P, Aliyu GG, Constantine N, Abimiku A, Carr JK, Vertefeuille J, Blattner W.

J Infect Dis. 2012 Apr 15;205(8):1239-47. doi: 10.1093/infdis/jis103. Epub 2012 Feb 21.

PMID:
22357663
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.

Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, Blattner WA, Sobieszczyk M, Suriyanon V, Kalichman A, Weiner DB, Baden LR; NIAID HIV Vaccine Trials Network.

PLoS One. 2012;7(1):e29231. doi: 10.1371/journal.pone.0029231. Epub 2012 Jan 5.

PMID:
22242162
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections.

Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, Lapedes AS, Shen T, Gaschen B, Krishnamoorthy M, Li H, Decker JM, Salazar-Gonzalez JF, Wang S, Jiang C, Gao F, Swanstrom R, Anderson JA, Ping LH, Cohen MS, Markowitz M, Goepfert PA, Saag MS, Eron JJ, Hicks CB, Blattner WA, Tomaras GD, Asmal M, Letvin NL, Gilbert PB, Decamp AC, Magaret CA, Schief WR, Ban YE, Zhang M, Soderberg KA, Sodroski JG, Haynes BF, Shaw GM, Hahn BH, Korber B.

PLoS Pathog. 2011 Sep;7(9):e1002209. doi: 10.1371/journal.ppat.1002209. Epub 2011 Sep 29.

PMID:
21980282
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.

Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R; NIAID HIV Vaccine Trials Network 044 Study Team.

J Infect Dis. 2011 Nov 15;204(10):1541-9. doi: 10.1093/infdis/jir615. Epub 2011 Sep 21.

PMID:
21940420
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).

Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC; NIAID HIV Vaccine Trials Network.

PLoS One. 2011;6(8):e21225. doi: 10.1371/journal.pone.0021225. Epub 2011 Aug 3.

PMID:
21857901
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk